Vasoconstrictor and systemic activities of topical steroids.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001623:Betamethasone / Q000008:administration & dosage; D001681:Biological Assay; D002256:Carbonic Anhydrases / Q000032:analysis; D005260:Female; D005443:Flumethasone / Q000008:administration & dosage; D005446:Fluocinolone Acetonide / Q000008:administration & dosage; D005478:Flurandrenolone / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D008598:Menstruation / Q000187:drug effects; D051379:Mice; D051381:Rats; D012869:Skin Absorption; D014222:Triamcinolone Acetonide / Q000008:administration & dosage; D014599:Uterus / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014666:Vasomotor System / Q000187:drug effects*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D005478:Flurandrenolone; D001623:Betamethasone; D002256:Carbonic Anhydrases; D014222:Triamcinolone Acetonide; D005443:Flumethasone; D006854:Hydrocortisone